Tranilast

CAS: 53902-12-8

Ref. TM-T2690

Produktinformation

• Name: Tranilast
• Synonyme: SB 252218, MK 341, 2-(3,4-Dimethoxycinnamoylamino)benzoic acid, 2-({(2E)-3-[3,4-bis(methyloxy)phenyl]prop-2-enoyl}amino)benzoic acid, 2-[3-(3,4-Dimethoxyphenyl)prop-2-enoylamino]benzoic acid, 2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]benzoic acid, 2-{[(2E)-3-(3,4-Dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid, 3,4-Daa, Benzoic acid, 2-[[(2E)-3-(3,4-dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]-, Benzoic acid, 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propen-1-yl]amino]-, Benzoic acid, 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-, Mk 341, N-(3,4-Dimethoxycinnamoyl)anthranilic acid, Rizaben, Tranpro, benzoic acid, 2-[[(2E)-3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]-

Beschreibung

Tranilast (SB 252218), an antiallergic drug, suppresses lipid mediator and cytokine release from inflammatory cells, therefore utilized in the treatment of

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 327.33
• Formel: C₁₈H₁₇NO₅
• Reinheit: 100% - 99.90%
• Farbe/Form: White With Light Yellow Crystalline Powder